moiety < molecular < molecule

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 46.
[0-20] [0 - 20][0 - 46][20-40]

Ident.	Authors (with country if any)	Title
000050 (2011)	Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru Harada	Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000051 (2008)	Atsushi Taga [Japon] ; Soichiro Kita ; Kaori Nishiura [Japon] ; Tomonori Hayashi [Japon] ; Mitsuhiro Kinoshita ; Atsushi Sato [Japon] ; Kentaro Suzuki [Japon] ; Shuji Kodama [Japon] ; Kazuaki Kakehi	Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary
000066 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000069 (2016)	Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]	Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000134 (2013)	F. Behrens [Allemagne] ; M. Köhm [Allemagne]	Personalisierte Medizin bei Zytokin-gerichteten Therapien
000173 (2013)	Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]	Aryl hydrocarbon receptor and experimental autoimmune arthritis
000179 (2009)	Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto	Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000212 (2013)	Pierre Gangloff	Biothérapie et odontologie
000246 (2011)	Bernard Bannwarth [France]	Prise en charge thérapeutique de l’inflammation d’origine rhumatismale
000300 (2012)	Joerg-Patrick Stübgen [États-Unis]	Targeted immunotherapy trials for idiopathic inflammatory myopathies
000380 (2013)	J. Ducreux [Belgique] ; A. Nzeusseu Toukap [Belgique] ; F. A. Houssiau [Belgique] ; P. Durez [Belgique] ; B. Lauwerys [Belgique]	THU0108 Global molecular effects of tocilizumab therapy in synovial biopsies of early RA patients
000469 (2013)	J. Ducreux [Belgique] ; P. Durez [Belgique] ; A. Nzeusseu Toukap [Belgique] ; F. A. Houssiau [Belgique] ; B. R. Lauwerys [Belgique]	OP0188 Tocilizumab and Rituximab, but Not Adalimumab, Display Highly Concordant Molecular Effects in the Rheumatoid Arthritis Synovium
000584 (2012)	Chia Chi Sun [États-Unis] ; Valentina Vaja [États-Unis, Italie] ; Jodie L. Babitt [États-Unis] ; Herbert Y. Lin [États-Unis]	Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
000611 (2013)	K. Saito [Japon] ; K. Hanami [Japon] ; S. Hirata [Japon] ; S. Kubo [Japon] ; M. Nawata [Japon] ; K. Yamaoka [Japon] ; S. Nakayamada [Japon] ; K. Nakano [Japon] ; Y. Tanaka [Japon]	FRI0251 Comparison of lipid profile including high molecular weight adiponectin (HMW-AN) after treatment with three different biologics in the patients with bio-naïve rheumatoid arthritis (RA)
000877 (2014)	Yusei Miyazaki [Japon] ; Masaaki Niino [Japon]	Molecular targeted therapy against B cells in multiple sclerosis
000A92 (2012)	Afsha A. Topal [Inde] ; Rachita S. Dhurat [Inde]	Scleroderma therapy: clinical overview of current trends and future perspective
000B67 (2012)	Sandeep Kumar [États-Unis] ; Mark A. Mitchell [États-Unis] ; Bonita Rup [États-Unis] ; Satish K. Singh [États-Unis]	Relationship between potential aggregation‐prone regions and HLA‐DR‐binding T‐cell immune epitopes: Implications for rational design of novel and follow‐on therapeutic antibodies
000B95 (2013)	I. Ben-Zvi ; T. Krichely-Vachdi ; O. Feld ; M. Lidar ; S. Kivity [Israël] ; A. Livneh	THU0390 Prolonged disease-free interval in familial mediterranean fever: A distinct subset with unique clinical, demographic and molecular characteristics
000C04 (2012)	D A Katzka [États-Unis] ; E V Loftus Jr [États-Unis] ; M. Camilleri [États-Unis]	Evolving Molecular Targets in the Treatment of Nonmalignant Gastrointestinal Diseases
000C90 (2012)	Hiromoto Hisada [Japon] ; Hiroko Tsutsumi [Japon] ; Hiroki Ishida [Japon] ; Yoji Hata [Japon]	High production of llama variable heavy-chain antibody fragment (VHH) fused to various reader proteins by Aspergillus oryzae
000D16 (2009)	Guzman M. Renato	B Cell Depletion in Early Rheumatoid Arthritis: A New Concept in Therapeutics

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "molecular" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "molecular" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    molecular
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021